Ildong to co-develop GLP-1 fusion protein formulations with Genexine

Published: 2008-12-10 06:50:00
Updated: 2008-12-10 06:50:00
Ildong Pharm and Genexine Co., a drug development biotech, entered into a collaboration agreement by signing a contract of the Product co-development.

The contract encompasses co-commercialization of GLP-1 (glucagon-like peptide-1) fusion protein formulation using Genexine's proprietary hybri...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.